These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1799938)

  • 1. Synthesis and biological activities of new 2-substituted 1,4-benzoxazine derivatives.
    Kajino M; Shibouta Y; Nishikawa K; Meguro K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2896-905. PubMed ID: 1799938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of new 1,4-benzothiazine derivatives.
    Kajino M; Mizuno K; Tawada H; Shibouta Y; Nishikawa K; Meguro K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2888-95. PubMed ID: 1799937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel potassium channel activators: synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Matsumoto Y; Tsuzuki R; Matsuhisa A; Takayama K; Yoden T; Uchida W; Asano M; Fujita S; Yanagisawa I; Fujikura T
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):103-14. PubMed ID: 8582029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiropiperidines. I. Synthesis of 1'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one derivatives and evaluation of their antihypertensive activity.
    Takai H; Obase H; Teranishi M; Karasawa A; Kubo K; Shuto K; Kasuya Y; Hashikami M; Karashima N; Shigenobu K
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1129-39. PubMed ID: 4028295
    [No Abstract]   [Full Text] [Related]  

  • 5. One pot synthesis of some new substituted hexahydro 2H-1,3-benzoxazine derivatives.
    Safak C; Simsek R; Altas Y; Erol K; Boydag S
    Boll Chim Farm; 1996 Sep; 135(8):482-5. PubMed ID: 9035560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
    Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers.
    Yamamoto S; Hashiguchi S; Miki S; Igata Y; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):734-45. PubMed ID: 8681405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of calcium antagonists. 2. Synthesis and biological activity of 11-[[4-[4-(4-fluorophenyl)-1-piperazinyl]butyryl]amino]-6,11- dihydrodibenzo[b,e]-thiepin maleate and related compounds.
    Kurokawa M; Sato F; Fujiwara I; Hatano N; Honda Y; Yoshida T; Naruto S; Mastumoto J; Uno H
    J Med Chem; 1991 Mar; 34(3):927-34. PubMed ID: 2002473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Touzeau F; Arrault A; Guillaumet G; Scalbert E; Pfeiffer B; Rettori MC; Renard P; Mérour JY
    J Med Chem; 2003 May; 46(10):1962-79. PubMed ID: 12723959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potassium channel activators. II. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification of the aromatic part.
    Matsumoto Y; Tsuzuki R; Matsuhisa A; Masuda N; Yamagiwa Y; Yanagisawa I; Shibanuma T; Nohira H
    Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):971-9. PubMed ID: 10434398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New substituted 1,4-benzoxazine derivatives with potential intracellular calcium activity.
    Bourlot AS; Sánchez I; Dureng G; Guillaumet G; Massingham R; Monteil A; Winslow E; Pujol MD; Mérour JY
    J Med Chem; 1998 Aug; 41(17):3142-58. PubMed ID: 9703461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
    Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
    J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
    Rovnyak GC; Atwal KS; Hedberg A; Kimball SD; Moreland S; Gougoutas JZ; O'Reilly BC; Schwartz J; Malley MF
    J Med Chem; 1992 Aug; 35(17):3254-63. PubMed ID: 1387168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-(1-piperazinyl)-1H-1,2,4-triazol-3-amines as antihypertensive agents.
    Meyer WE; Tomcufcik AS; Chan PS; Haug M
    J Med Chem; 1989 Mar; 32(3):593-7. PubMed ID: 2918504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl 5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate dihydrochloride (NIP-101).
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2370-6. PubMed ID: 1446357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 3-substituted 1-[4-(2-indol-3-ylethyl)piperazinyl]ureas as potential antihypertensive agents.
    Glamkowski EJ; Reitano PA; Woodward DL
    J Pharm Sci; 1978 Dec; 67(12):1773-4. PubMed ID: 722502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.